Company intelligence / Profile preview

Mendor

Espoo, Finland

Ownership: Private
Development stage: Other

Overview

Mendor developed and commercialized a portable all-in-one blood glucose meter ('Discreet') paired with a cloud-based software ('Balance') for daily diabetes management and comprehensive glucose data analytics; the solution was designed for people requiring frequent blood glucose monitoring and was sold in multiple European markets before the company underwent asset sale.

Therapeutic areas: Endocrinology
Modalities: DeviceDigital health software
Industry: Metabolite Diagnostics

Partnerships

Merck SeronoMediqNovartis Finland

Beyond the preview

Go deeper on Mendor.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mendor.

Explore the full profile